12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
NCT00373542
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Restless Legs Syndrome (RLS)
Restless Legs Syndrome
Interventions
DRUG:
ropinirole CR-RLS
Sponsor
GlaxoSmithKline